Lee's Pharmaceutical Holdings Limited (HK:0950)
:0950
Want to see HK:0950 full AI Analyst Report?
Total Valuation
Lee's Pharmaceutical Holdings Limited has a market cap or net worth of HK$659.50M. The enterprise value is HK$637.53M.
Market CapHK$659.50M
Enterprise ValueHK$637.53M
Share Statistics
Lee's Pharmaceutical Holdings Limited has 588,835,300 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding588,835,300
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Lee's Pharmaceutical Holdings Limited’s return on equity (ROE) is 0.04 and return on invested capital (ROIC) is 1.67%.
Return on Equity (ROE)0.04
Return on Assets (ROA)0.03
Return on Invested Capital (ROIC)1.67%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee1.41M
Profits Per Employee71.32K
Employee Count1,022
Asset Turnover0.41
Inventory Turnover1.94
Valuation Ratios
The current PE Ratio of Lee's Pharmaceutical Holdings Limited is 9.7. Lee's Pharmaceutical Holdings Limited’s PEG ratio is 0.00.
PE Ratio9.7
PS Ratio0.62
PB Ratio0.44
Price to Fair Value0.44
Price to FCF8.83
Price to Operating Cash Flow2.46
PEG Ratio0.00
Income Statement
In the last 12 months, Lee's Pharmaceutical Holdings Limited had revenue of 1.44B and earned 91.94M in profits. Earnings per share was 0.16.
Revenue1.44B
Gross Profit729.56M
Operating Income61.48M
Pretax Income72.89M
Net Income91.94M
EBITDA217.13M
Earnings Per Share (EPS)0.16
Cash Flow
In the last 12 months, operating cash flow was 335.60M and capital expenditures -66.63M, giving a free cash flow of 268.97M billion.
Operating Cash Flow335.60M
Free Cash Flow268.97M
Free Cash Flow per Share0.46
Dividends & Yields
Lee's Pharmaceutical Holdings Limited pays an annual dividend of HK$0.022, resulting in a dividend yield of 2.92%
Dividend Per ShareHK$0.022
Dividend Yield2.92%
Payout Ratio28.31%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.65
52-Week Price Change-11.54%
50-Day Moving Average1.36
200-Day Moving Average1.70
Relative Strength Index (RSI)42.10
Average Volume (3m)5.40M
Important Dates
Lee's Pharmaceutical Holdings Limited upcoming earnings date is Sep 2, 2026, TBA (Confirmed).
Last Earnings DateMar 30, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date―
Financial Position
Lee's Pharmaceutical Holdings Limited as a current ratio of 1.03, with Debt / Equity ratio of 15.17%
Current Ratio1.03
Quick Ratio0.71
Debt to Market Cap0.34
Net Debt to EBITDA-0.18
Interest Coverage Ratio5.48
Taxes
In the past 12 months, Lee's Pharmaceutical Holdings Limited has paid 22.27M in taxes.
Income Tax22.27M
Effective Tax Rate0.31
Enterprise Valuation
Lee's Pharmaceutical Holdings Limited EV to EBITDA ratio is 3.94, with an EV/FCF ratio of 8.44.
EV to Sales0.60
EV to EBITDA3.94
EV to Free Cash Flow8.44
EV to Operating Cash Flow2.57
Balance Sheet
Lee's Pharmaceutical Holdings Limited has HK$349.90M in cash and marketable securities with HK$310.27M in debt, giving a net cash position of HK$39.63M billion.
Cash & Marketable SecuritiesHK$349.90M
Total DebtHK$310.27M
Net CashHK$39.63M
Net Cash Per ShareHK$0.07
Tangible Book Value Per ShareHK$0.94
Margins
Gross margin is 51.52%, with operating margin of 4.28%, and net profit margin of 6.40%.
Gross Margin51.52%
Operating Margin4.28%
Pretax Margin5.08%
Net Profit Margin6.40%
EBITDA Margin15.12%
EBIT Margin4.28%
Analyst Forecast
The average price target for Lee's Pharmaceutical Holdings Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast2.57%
EPS Growth Forecast-1.27%